Latest NanoBiotech & NanoMedicine Posters
Delivery of RNP complexes for CRISPRi (dCas9) silencing in vitro and in vivo using crystalline ultrasmall particles (CUSP)
GM Unger*, VL Korman, BT Kren, DL Tobolt
RoverMed BioSciences;, Minneapolis VA Healthcare Systems
Genetic Engineering in Male Sterility for Hybrid Variety Development
Abir Hasan Joy
Multiplex miRNA Profiling for Biomarker Discovery and Verification Studies Using the FirePlex® Platform
M. Tackett, B. Heinrich, I. Diwan, G. Tejada, C. Rafferty, E. Atabakhsh, and D. Pregibon
Abcam, Inc. One Kendall Square Suite B2304, Cambridge, MA 02139.
Effect of Gold Nanosemicubes with and without laser exposure on Oral Squamous Cell Carcinoma cell line
Sara M. Ali 1, Mohamed H. Elmallahy2, Amira M. Gamal-Eldeen 3 and Seham A. Abdel-Ghani 4
1. Lecturer of Oral Pathology, Faculty of Dentistry, MSA University. 2. Professor of Oral Pathology, Faculty of Dentistry, Ain Shams University. 3. Professor of Biochemistry, Biochemistry Department, National Research Center, Cairo, Egypt. 4. Lecturer of Oral Pathology, Faculty of Dentistry, Ain Shams University.
Targeting Induced Oral Squamous Cell Carcinoma Using Panel of Chemotherapeutics Loaded on Gold Nanoparticles (Experimental Study)
Marwa M. Essawy1,2, Sagy L. Assar1, Hend M. Abdel Hamid1, Sahar M. El-Sheikh1, Fatma H. El-Didi1, Zeinab E. Darwish1, Hanaa S. Raslan1, Ghada M. Mourad2,3, Marwa M. Afifi1.
1. Oral Pathology Department, Faculty of Dentistry, Alexandria University, Egypt. 2. Center of Excellence for Research in Regenerative Medicine and Applications (CERRMA), Faculty of Medicine, Alexandria University, Egypt. 3. Histology and Cell Biology Department, Faculty of Medicine, Alexandria University, Egypt.
Stanley Meyer Designs
Auto Truck Mechanics and Auto Electricians
High-throughput Carbonic Anhydrase Activity and Inhibitor Screening Assays
Suratna Hazra, Ph.D., Grigoriy Tchaga, Ph.D., and Gordon Yan, Ph.D.
A High-Throughput Assay to Measure Phosphoenolpyruvate Carboxykinase (PEPCK) Activity in Biological Samples
Shunan Li, Ph.D., Keith Cheung, Ph.D. Grigoriy Tchaga, Ph.D. Jianping Xu, Ph.D. and Gordon Yan, Ph.D. Acknowledments: Kyle Schmitt, Ph.D • Tanvi Gangakhedkar • Gustavo Chavarria, Ph.D. • Kwang Kim, Ph.D. • Robert Stephenson, Ph.D. • Hong Qu, Ph.D.
Quantitative Assessment of the Intracellular Uptake of Chlorotoxin in a U87 Human Glioma Mouse Model for the Targeted Drug Delivery System
Alan D. Roberts, Joseph O. Johnson, Aleksandra Karolak, Norma Alcantar, Katarzyna A. Rejniak, Marzenna Wiranowska
Research Scholarly Concentration Program Morsani College of Medicine; Moffitt Cancer Research Center
Nanoparticles designed for intranasal delivery of siRNA and DNA to brain
University of South Florida
Humanin nanoparticles for reducing pathological factors characteristic of age-related macular degeneration
Aum Solanki, Rudy Smalling, Abraham Parola, Ilana Nathan, Yashwant Pathak, Vijaykumar Sutariya
University of South Florida, Ben-Gurion University
Artificial multimeric proteins with programmable biological and chemical functions
Piotr M. Skowron, Łukasz Janus, Olga Żołnierkiewicz, Małgorzata Skowron, Joanna Jeżewska-Frąckowiak, Daria Krefft, Dawid Nidzworski, Kasjan Szemiako, Natalia Maciejewska, Marta Nowak, Alicja Wiercińska-Drapało, Grzegorz Węgrzyn, Aneta Szymańska, Agnieszka Żylicz-Stachula
University of Gdansk, Faculty of Chemistry, Dept. of Molecular Biotechnology, Gdansk, Poland
Subcutaneous Delivery of Hepatocyte Targeted sub-50 nm Nanoencapsulated siRNA Mediates Gene Silencing
BT Kren, D Tolbot, V Korman, GM Unger
University of Minnesota, GeneSegues Therapeutics
ELECTROWETTING CHIP ON PAPER BASED SUBSTRATE
Nurul Amziah Md Yunus and Noor Faezah Ismail
Universiti Putra Malaysia
Targeted Nanocapsules for Hepatic Cell-type and Tumor-specific In Vivo Delivery of Plasmids or Drugs
Gretchen M Unger2, Vicci Korman2, Diane Tobolt2, Betsy T Kren1
1Department of Medicine, University of Minnesota Medical School, VAMC Minneapolis, MN and 2GeneSegues, Inc., Chaska, MN.
Priming stategy with sub-50 nanometer capsules and RNAi cargo (“GS-10”) to enhance RNAi and immunotherapy responses
Lucas P. Nacusi, Vicci L. Korman, Alex J. Pretti, Diane L. Tobolt, Alvaro Mendoza, Gretchen M. Unger
GeneSegues Therapeutics, Minnetonka, MN 55343
Passive topical administration of nucleic acids to targeted skin cells via sub-50 nm capsules
G Unger1, V Korman1, D Tobolt1, M Fuentes de Abin2, R Kaspar3, B Kren2, J Ballantyne4, M Murtaugh2
1GeneSegues, Inc., Chaska, MN; 2University of Minnesota, Mpls., MN; 3Transderm, Inc., Santa Cruz, CA; 4Aldevron, Fargo, ND
www.thebraindomain.org: Science Writing for Public Engagement
Bartley, O.; Rienecker, K.; Stickland, R.; Pass, R.; Bunga, A.; Cross, E.; & Fagg, J.
Cardiff University, Wales, UK.
Subcutaneous Delivery of Diagnostics and RNAi to Primary and Metastatic Tumors via Actively-targeted sub-50 nm (s50) Capsules
Vicci L. Korman1, Lucas Nacusi1, Alex J. Pretti1, Diane L. Tobolt1, J. David Robertson2, Gretchen M. Unger1
1GeneSegues Therapeutics, Eden Prairie, MN 55347; 2University of Missouri, Columbia, MO 65211